{
  "pmcid": "6433324",
  "sha256": "0faeb5a5e0f3ecbc44edde87e0b2a2d4428efa36f39f59d7655d0ba54350d843",
  "timestamp_utc": "2025-11-10T00:01:38.741227+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.85071143995447,
    "reading_ease": 45.72644090305448,
    "word_count": 251
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Liver Transplantation for Non-Resectable Colorectal Liver Metastases"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "No randomisation or blinding was employed."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included good performance status and absence of extrahepatic disease. Conducted in Norway."
      },
      "Intervention": {
        "score": 2,
        "evidence": "All 23 patients received LT."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess the impact of liver transplantation (LT) on long-term quality of life (QoL) and overall survival (OS) in patients with non-resectable colorectal liver metastases (CRLM)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was OS at 2 years, with secondary outcomes including disease-free survival and QoL."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "No randomisation or blinding was employed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "No randomisation or blinding was employed."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "All 23 patients received LT."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "All 23 patients received LT."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The mean difference in fatigue scores between those who survived and those who did not was 18.2 (95% CI 2.1 to 34.3; p = 0.033)."
      },
      "Harms": {
        "score": 1,
        "evidence": "At 3 months post-LT, patients reported reduced QoL, physical function, and increased dyspnoea."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The study was registered at ClinicalTrials.gov (NCT01311453)"
      },
      "Funding": {
        "score": 1,
        "evidence": "funded by institutional sources."
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}